Antitumor activity of interleukin‐21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli
Open Access
- 18 September 2002
- journal article
- Published by Wiley in FEBS Letters
- Vol. 528 (1-3) , 70-76
- https://doi.org/10.1016/s0014-5793(02)03254-4
Abstract
Interleukin‐21 (IL‐21) has recently been identified as a novel 4‐helix‐bundle type I cytokine possessing a cytokine receptor γ chain essential for the immune response. We report the preparation and f...Keywords
This publication has 24 references indexed in Scilit:
- IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell ActivationImmunity, 2002
- Recombinant antibodies for cancer diagnosis and therapyExpert Opinion on Biological Therapy, 2001
- Application of Combined Reagent Solution to the Oxidative Refolding of Recombinant Human Interleukin 6.CHEMICAL & PHARMACEUTICAL BULLETIN, 2001
- Optimized Gene Synthesis, High Level Expression, Isotopic Enrichment, and Refolding of Human Interleukin-5Protein Expression and Purification, 1997
- High Level Expression and Refolding of Mouse Interleukin 4 Synthesized in Escherichia coliPublished by Elsevier ,1995
- Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regionsMolecular Immunology, 1994
- "Diabodies": small bivalent and bispecific antibody fragments.Proceedings of the National Academy of Sciences, 1993
- Cytoplasmic and periplasmic expression of a highly basic protein, human interleukin 4, inEscherichia coliJournal of Industrial Microbiology & Biotechnology, 1990
- Purification of human interleukin-4 produced in Escherichia coliGene, 1989
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970